Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology

Versailles Hospital310 enrolled

Overview

this is an observational study that involves providing a questionnaire to patients consulting in psychiatry, addictology (other than tobacco) and endocrinology to assess their knowledge of tobacco risks and access to smoking cessation aids

Study Type

OBSERVATIONAL

Enrollment

310

Conditions

Consumption, Tobacco

Interventions

questionnaireOTHER

Tobacco Use and Risk Questionnaire

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients \> 18 years * Men and women * who comes for consultation during the study * Psychiatry on CMP or HDJ, regardless of diagnosis or smoking status * Endocrinology in consultation or HDJ * In addictology at CSAPA Exclusion Criteria: * Patient unable to complete questionnaire (not speaking French, confused, alcoholics, etc.) * Refusal to complete questionnaire

Locations (2)

Centre Hospitalier de Versailles

Le Chesnay, France

Hôpital Ferdinand Widal

Paris, France

Outcomes

Primary Outcomes

to Assess the level of information on tobacco-related risks of patients with questionnaire

to Assess the level of information on tobacco-related risks of patients monitored for psychiatric disorders by comparing them to patients monitored for an addiction other than tobacco or to patients monitored for a chronic disease

Time frame: at the end of study, average 2 month

to Assess access to smoking cessation aids for smokers and ex-smokers with questionnaire

to Assess access to smoking cessation aids for smokers and ex-smokers among psychiatric patients compared to smokers and ex-smokers among patients who have been monitored for an addiction other than tobacco or among patients who have been monitored for a chronic disease (endocrine).

Time frame: at the end of study, average 2 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.